BCPS -- 3. Anticoagulation Drug Trials for Stroke Prevention in Atrial Fibrillation / David A. Manly, MD and Christopher B. Granger, MD -- 4. Risk Stratification in Atrial Fibrillation / Farhan Shahid, MBBS, BSc, Mikhail Dzeshka, MD, Eduard Shantsila, MD, PhD and Gregory Y.H. Lip, MD, FRCP, FACC, FESC -- 5. Subclinical Atrial Fibrillation: Definition, Prevalence, and Treatment Strategies / Abhinav Sharma, MD, FRCPC and Renato D. Lopes, MD, MHS, PhD -- 6. The New Anticoagulation Clinic / Anne E. Rose, PharmD -- 7. Management of Bleeding Associated With Anticoagulation / Geno J. Merli, MD, MACP, FSVM, FHM and Lynda Thomson, PharmD -- 8. Periprocedural Management of Anticoagulation in Patients With Atrial Fibrillation / Richard Weachter, MD and Greg Flaker, MD -- 9. Special Situations: Anticoagulation for Cardioversion / Chad Ward, MD and Michael C. Giudici, MD, FACC, FACP, FHRS -- 10. Anticoagulation for Ablation Procedures / Michael C. Giudici, MD, FACC, FACP, FHRS and Bria Giacomino, DO -- 11. Surgical and Implanted Devices for the Left Atrial Appendage / Sandeep Gautam, MD, MPH and Joshua Payne, MD, MPH -- 12. Patients Taking Oral Anticoagulants for Atrial Fibrillation With Concomitant Complex Disease States / William J. Hucker, MD, PhD, Mitul Kanzaria, MD, and John U. Doherty, MD, FACC -- 13. Stroke and Atrial Fibrillation: The Neurologist's Perspective / Luciana Catanese, MD and Robert G. Hart, MD -- 14. Stroke and Atrial Fibrillation in Chronic Kidney Disease and Dialysis / David Collister, MD and Michael Walsh, MD, PhD. |